Allied Corp. and Hollister Biosciences product Tactical Relief™ now in distribution
by CM Staff
Allied has contributed the brand, artwork, logos, packaging design and marketing for all Tactical Relief™ products.
KELOWNA — Allied Corp. – an international medicinal cannabis company focused on creating and providing cannabinoid health solutions to address PTSD, anxiety, stress and inflammation announces an update to a distribution deal with Hollister Biosciences. Under the arrangement, Allied’s Tactical Relief™ branded products will be sold in licensed dispensaries across California. Through their distribution network, Hollister’s other brands have brought in excess of $40 million revenue between January and December 2020.
Allied has contributed the brand, artwork, logos, packaging design and marketing for all Tactical Relief™ products. Hollister has completed all aspects of production and procurement of underlying materials. Allied will be supporting the marketing and brand presence with authentic veteran representation.
“We are excited to partner with Hollister to bring our innovative and differentiated line up of quality Tactical Relief™ products to consumers in Hollister’s distribution network. Hollister has a proven track record of bringing successful products to market. The potential market for Tactical Relief™ products in the states that Hollister distributes to is substantial. Together, we hope to build a solid recurring revenue pipeline,” said Calum Hughes, Founder & CEO of Allied Corp.
“Tactical Relief™ is Allied’s flagship brand targeting PTSD, a debilitating condition that is all too common amongst people who are often serving in the front lines,” said Adam Smith, a Green Beret, veteran, and US representative at Allied. “We are excited to be partnering with Hollister to greatly expand Tactical Relief’s reach to those suffering from the serious effects of PTSD.”
“We are very excited to be launching Tactical Relief™ to Veterans, 1st responders, and others suffering from PTSD through our distribution network,” said Carl Saling, Founder, CEO and Director of Hollister Biosciences Inc.